These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15777573)

  • 1. Management of patients with hepatitis B virus-induced cirrhosis.
    Fung SK; Lok AS
    J Hepatol; 2005; 42 Suppl(1):S54-64. PubMed ID: 15777573
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosis.
    Zoulim F; Radenne S; Ducerf C
    Liver Transpl; 2008 Oct; 14 Suppl 2():S1-7. PubMed ID: 18825719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons.
    Soriano V; Sheldon J; Ramos B; Núñez M
    AIDS; 2006 Feb; 20(3):451-3. PubMed ID: 16439880
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of HBV-related cirrhosis.
    Vallet-Pichard A; Mallet V; Costentin CE; Pol S
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):527-35. PubMed ID: 19485793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and end-stage liver disease.
    Weisberg IS; Brown RS; Sigal SH
    Clin Liver Dis; 2007 Nov; 11(4):893-916, ix. PubMed ID: 17981234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
    Liaw YF
    Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of chronic hepatitis B virus infection: what determines prognosis after cirrhotic decompensation?
    Wei L
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1631-2. PubMed ID: 19120855
    [No Abstract]   [Full Text] [Related]  

  • 8. [Emphasis on the antiviral therapy for decompensated hepatitis B-related cirrhosis].
    Fu QC; Chen CW
    Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(23):1585-6. PubMed ID: 20979741
    [No Abstract]   [Full Text] [Related]  

  • 9. [Forestalling cirrhosis. When to test for hepatitis B, how to treat? (interview by Dr. med. Dirk Einecke)].
    Gillessen A
    MMW Fortschr Med; 2010 Apr; 152(16):24-5. PubMed ID: 20464873
    [No Abstract]   [Full Text] [Related]  

  • 10. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
    Wang FS; Zhang Z
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
    Viganò M; Colombo M; Aroldi A; Lunghi G; Manenti E; Ponticelli C; Lampertico P
    Antivir Ther; 2005; 10(6):709-13. PubMed ID: 16218169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic hepatitis B: recommendations from an Italian workshop.
    Carosi G; Rizzetto M
    Dig Liver Dis; 2008 Aug; 40(8):603-17. PubMed ID: 18499540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance.
    Moskovitz DN; Osiowy C; Giles E; Tomlinson G; Heathcote EJ
    J Viral Hepat; 2005 Jul; 12(4):398-404. PubMed ID: 15985011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modern nucleoside analogs against hepatitis B. Hope for a better prognosis].
    MMW Fortschr Med; 2010 Apr; 152(16):25. PubMed ID: 20464874
    [No Abstract]   [Full Text] [Related]  

  • 16. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.
    Soriano V; Puoti M; Peters M; Benhamou Y; Sulkowski M; Zoulim F; Mauss S; Rockstroh J
    AIDS; 2008 Jul; 22(12):1399-410. PubMed ID: 18614862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactic acidosis during Entecavir treatment in decompensated hepatitis B virus-related cirrhosis.
    Marzano A; Marengo A; Marietti M; Rizzetto M
    Dig Liver Dis; 2011 Dec; 43(12):1027-8. PubMed ID: 21782535
    [No Abstract]   [Full Text] [Related]  

  • 18. Quiet reflection after effective action: hepatitis B viraemia and hepatocellular carcinoma recurrence.
    Abdo AA; Sanai FM
    Liver Int; 2008 Apr; 28(4):423-5. PubMed ID: 18339067
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of cirrhosis due to chronic hepatitis C.
    Everson GT
    J Hepatol; 2005; 42 Suppl(1):S65-74. PubMed ID: 15777574
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic HBeAg-negative viral gepatitis B: treatment is essential and possible].
    Isakov VA
    Eksp Klin Gastroenterol; 2007; (5):40-5. PubMed ID: 18389596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.